Bleeding events are associated with an increase in markers of inflammation in acute coronary syndromes: An ACUITY trial substudy

Journal of Thrombosis and Thrombolysis

Volumn 31, Issue 2, 2011, Pages 139-145

  Campbell, Charles L ^a,b   Steinhubl, Steven R ^c   Hooper, William C ^e   Jozic, Joseph ^f   Smyth, Susan S ^a,b   Bernstein, Debra ^d   De Staercke, Christine ^e   Syros, George ^g   Negus, Brian H ^h   Stuckey, Thomas ⁱ   Stone, Gregg W ^g   Mehran, Roxana ^j   Dangas, George ^k  

^a UNIVERSITY OF KENTUCKY   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

^c GEISINGER MEDICAL CENTER   (United States)

^d MEDICINES COMPANY   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^g NewYork Presbyterian Hospital   (United States)

^h Chattanooga Heart Institute   (United States)

ⁱ LeBauer Cardiovascular Research Foundation   (United States)

^j MOUNT SINAI MEDICAL CENTER   (United States)

^k NONE

more..

Author keywords

Acute coronary syndromes; Bleeding events; Highly sensitive C reactive protein; Interleukin 1

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; HAPTOGLOBIN; HEMOGLOBIN; HEPARIN; HIRULOG; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL;

ACUTE CORONARY SYNDROME; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HEMORRHAGE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED;

EID: 79951721963     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-010-0513-1     Document Type: Article

References (35)

1. SV Rao JA Eikelboom CB Granger RA Harrington RM Califf JP Bassand 2007 Bleeding and blood transfusion issues in patients with non-ST-segment elevation acute coronary syndromes Eur Heart J 28 1193 1204 10.1093/eurheartj/ehm019 17456480 (Pubitemid 47343833)
2. SV Manoukian F Feit R Mehran MD Voeltz R Ebrahimi M Hamon GD Dangas AM Lincoff HD White JW Moses SB King III EM Ohman GW Stone 2007 Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial J Am Coll Cardiol 49 1362 1368 10.1016/j.jacc.2007.02.027 17394970 (Pubitemid 46476844)
3. X Yang KP Alexander AY Chen MT Roe RG Brindis SV Rao WB Gibler EM Ohman ED Peterson 2005 The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE national quality improvement initiative J Am Coll Cardiol 46 1490 1495 10.1016/j.jacc.2005.06.072 16226173 (Pubitemid 41446184)
4. SV Rao JG Jollis RA Harrington CB Granger LK Newby PW Armstrong DJ Moliterno L Lindblad K Pieper EJ Topol JS Stamler RM Califf 2004 Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes Jama 292 1555 1562 1:CAS:528:DC%2BD2cXot1aks7Y%3D 10.1001/jama.292.13. 1555 15467057 (Pubitemid 39314961)
5. E Nikolsky R Mehran HM Sadeghi CL Grines DA Cox E Garcia JE Tcheng JJ Griffin G Guagliumi T Stuckey M Turco M Fahy AJ Lansky GW Stone 2009 Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (controlled Abciximab and device investigation to lower late angioplasty complications) Trial JACC Cardiovasc Interv 2 624 632 10.1016/j.jcin.2009.05.004 19628185
6. R Mehran SJ Pocock GW Stone TC Clayton GD Dangas F Feit SV Manoukian E Nikolsky AJ Lansky A Kirtane HD White A Colombo JH Ware JW Moses EM Ohman 2009 Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial Eur Heart J 30 1457 1466 10.1093/eurheartj/ehp110 19351691
7. MT Roe AY Chen RH Mehta Y Li RG Brindis SC Smith Jr JS Rumsfeld WB Gibler EM Ohman ED Peterson 2007 Influence of inpatient service specialty on care processes and outcomes for patients with non ST-segment elevation acute coronary syndromes Circulation 116 1153 1161 10.1161/CIRCULATIONAHA.107.697003 17709638 (Pubitemid 47360217)
8. GW Stone B Witzenbichler G Guagliumi JZ Peruga BR Brodie D Dudek R Kornowski F Hartmann BJ Gersh SJ Pocock G Dangas SC Wong AJ Kirtane H Parise R Mehran 2008 Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2218 2230 1:CAS:528:DC%2BD1cXmt1Gju7Y%3D 10.1056/NEJMoa0708191 18499566 (Pubitemid 351724451)
9. BJ Doyle CS Rihal DA Gastineau DR Holmes Jr 2009 Bleeding, blood transfusion, and increased mortality after percutaneous coronary intervention: implications for contemporary practice J Am Coll Cardiol 53 2019 2027 10.1016/j.jacc.2008.12.073 19477350
10. E Fransen J Maessen M Dentener N Senden W Buurman 1999 Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery Chest 116 1233 1239 1:STN:280:DC%2BD3c%2FisFygsw%3D%3D 10.1378/chest.116.5.1233 10559080 (Pubitemid 29535973)
11. FA Wagener A Eggert OC Boerman WJ Oyen A Verhofstad NG Abraham G Adema Y van Kooyk T de Witte CG Figdor 2001 Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase Blood 98 1802 1811 1:CAS:528:DC%2BD3MXntFWgtrw%3D 10.1182/blood.V98.6.1802 11535514
12. V Jeney J Balla A Yachie Z Varga GM Vercellotti JW Eaton G Balla 2002 Pro-oxidant and cytotoxic effects of circulating heme Blood 100 879 887 1:CAS:528:DC%2BD38XlvVCltL4%3D 10.1182/blood.V100.3.879 12130498 (Pubitemid 34832613)
13. GW Stone JH Ware ME Bertrand AM Lincoff JW Moses EM Ohman HD White F Feit A Colombo BT McLaurin DA Cox SV Manoukian M Fahy TC Clayton R Mehran SJ Pocock 2007 Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial Jama 298 2497 2506 1:CAS:528:DC%2BD2sXhsVSlu7nJ 10.1001/jama.298.21.2497 18056903 (Pubitemid 350223536)
14. GW Stone M Bertrand A Colombo G Dangas ME Farkouh F Feit AJ Lansky AM Lincoff R Mehran JW Moses M Ohman HD White 2004 Acute catheterization and urgent intervention triage strategY (ACUITY) trial: study design and rationale Am Heart J 148 764 775 10.1016/j.ahj.2004.04.036 15523305
15. N Krivoy Z Adler R Saloma A Hawadie ZS Azzam 2008 Targeting C-reactive protein levels using high-dose atorvastatin before coronary artery bypass graft surgery Exp Clin Cardiol 13 171 174 1:CAS:528:DC%2BD1MXivFylsb4%3D 19343161
16. GW Stone BT McLaurin DA Cox ME Bertrand AM Lincoff JW Moses HD White SJ Pocock JH Ware F Feit A Colombo PE Aylward AR Cequier H Darius W Desmet R Ebrahimi M Hamon LH Rasmussen HJ Rupprecht J Hoekstra R Mehran EM Ohman 2006 Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2203 2216 1:CAS:528:DC%2BD28Xht1Chsb3L 10.1056/NEJMoa062437 17124018 (Pubitemid 44791162)
17. J Aoki AJ Lansky R Mehran J Moses ME Bertrand BT McLaurin DA Cox AM Lincoff EM Ohman HD White H Parise MB Leon GW Stone 2009 Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the acute catheterization and urgent intervention triage strategy trial Circulation 119 687 698 1:CAS:528:DC%2BD1MXht1Gmuro%3D 10.1161/CIRCULATIONAHA.108.804203 19171852
18. TY Wang L Xiao KP Alexander SV Rao MN Kosiborod JS Rumsfeld JA Spertus ED Peterson 2008 Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding Circulation 118 2139 2145 1:CAS:528:DC%2BD1cXhtlGls73L 10.1161/CIRCULATIONAHA.108.787143 18981304
19. FA Spencer M Moscucci CB Granger JM Gore RJ Goldberg PG Steg SG Goodman A Budaj G FitzGerald KA Fox 2007 Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 116 2793 2801 10.1161/CIRCULATIONAHA.107.694273 18025530 (Pubitemid 350291221)
20. J Yang J Wang S Zhu X Chen H Wu D Yang J Zhang 2008 C-reactive protein augments hypoxia-induced apoptosis through mitochondrion-dependent pathway in cardiac myocytes Mol Cell Biochem 310 215 226 1:CAS:528:DC%2BD1cXitlWns7g%3D 10.1007/s11010-007-9683-3 18165866
21. M Woodward GD Lowe LM Francis A Rumley SM Cobbe 2004 A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial J Thromb Haemost 2 1934 1940 1:CAS:528:DC%2BD2cXhtFagsLzL 10.1111/j.1538-7836.2004. 01017.x 15550024 (Pubitemid 40192746)
22. HG Welch KR Meehan LT Goodnough 1992 Prudent strategies for elective red blood cell transfusion Ann Intern Med 116 393 402 1:STN:280:DyaK387ktlequw%3D%3D 1736773
23. T Shiga N Maeda K Kon 1990 Erythrocyte rheology Crit Rev Oncol Hematol 10 9 48 1:STN:280:DyaK3c3is1Ggtw%3D%3D 10.1016/1040-8428(90)90020-S 2183812 (Pubitemid 20132286)
24. P Zamboni S Lanzara F Mascoli A Caggiati A Liboni 2008 Inflammation in venous disease Int Angiol 27 361 369 1:STN:280:DC%2BD1cjgvVyrtA%3D%3D 18974697
25. FP Lafeber P Miossec LA Valentino 2008 Physiopathology of haemophilic arthropathy Haemophilia 14 Suppl 4 3 9 1:STN:280:DC%2BD1czpvFWrsA%3D%3D 10.1111/j.1365-2516.2008.01732.x 18494686 (Pubitemid 351728992)
26. R Shenkar MD Schwartz LS Terada JE Repine J McCord E Abraham 1996 Hemorrhage activates NF-kappa B in murine lung mononuclear cells in vivo Am J Physiol 270 L729 L735 1:CAS:528:DyaK28Xjt1Gqs70%3D 8967506
27. DR Meldrum R Shenkar BC Sheridan BS Cain E Abraham AH Harken 1997 Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart J Mol Cell Cardiol 29 2849 2854 1:CAS:528:DyaK2sXnt1Ggu7s%3D 10.1006/jmcc.1997. 0506 9344778 (Pubitemid 27466506)
28. JT Willerson PM Ridker 2004 Inflammation as a cardiovascular risk factor Circulation 109 II-2 II-10 10.1161/01.CIR.0000129535.04194.38
29. E Lindmark E Diderholm L Wallentin A Siegbahn 2001 Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy Jama 286 2107 2113 1:CAS:528:DC%2BD3MXot1Wqurc%3D 10.1001/jama.286.17.2107 11694151 (Pubitemid 34041595)
30. B Lindahl H Toss A Siegbahn P Venge L Wallentin 2000 Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease FRISC Study Group. Fragmin during Instability in Coronary Artery Disease N Engl J Med 343 1139 1147 1:STN:280: DC%2BD3cvpslCitA%3D%3D 10.1056/NEJM200010193431602 11036119
31. P Libby 2008 Role of inflammation in atherosclerosis associated with rheumatoid arthritis Am J Med 121 S21 S31 1:CAS:528:DC%2BD1cXhtlemsLrE 10.1016/j.amjmed.2008.06.014 18926166
32. A Dvorakova R Poledne 2004 Influenza-a trigger for acute myocardial infarction Atherosclerosis 172 391 1:CAS:528:DC%2BD2cXpsV2qsQ%3D%3D 10.1016/j.atherosclerosis.2003.09.005 15019551 (Pubitemid 38167551)
33. D Bainton GR Jones D Hole 1978 Influenza and ischaemic heart disease-a possible trigger for acute myocardial infarction? Int J Epidemiol 7 231 239 1:STN:280:DyaE1M%2Fms12nsg%3D%3D 10.1093/ije/7.3.231 721358 (Pubitemid 9045163)
34. T Goerge B Ho-Tin-Noe C Carbo C Benarafa E Remold-O'Donnell BQ Zhao SM Cifuni DD Wagner 2008 Inflammation induces hemorrhage in thrombocytopenia Blood 111 4958 4964 1:CAS:528:DC%2BD1cXmtlaiu74%3D 10.1182/blood-2007-11-123620 18256319
35. G Li AC Keenan JC Young MJ Hall Z Pamuklar EM Ohman SR Steinhubl SS Smyth 2007 Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophils Arterioscler Thromb Vasc Biol 27 1850 1856 1:CAS:528:DC%2BD2sXns1anu78%3D 10.1161/ATVBAHA.107.144576 17525363 (Pubitemid 47207182)